Litigation Details for AbbVie Inc. v. Boehringer Ingelheim International GMBH (D. Del. 2017)
✉ Email this page to a colleague
AbbVie Inc. v. Boehringer Ingelheim International GMBH (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-08-02 |
| Court | District Court, D. Delaware | Date Terminated | 2019-05-15 |
| Cause | 35:0145 | Assigned To | Mitchell S. Goldberg |
| Jury Demand | None | Referred To | Richard A. Lloret |
| Patents | 9,018,361; 9,090,867; 9,096,666; 9,255,143; 9,266,949 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in AbbVie Inc. v. Boehringer Ingelheim International GMBH
The biologic drug covered by the patents cited in this case is ⤷ Sign Up .
Details for AbbVie Inc. v. Boehringer Ingelheim International GMBH (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-05-30 | 111 | Redacted Document | 2 See, e.g., Non-formulation U.S. Patent No. 9,018,361 at 3:4-12 (“In certain embodiments, the … cited in the specification of, U.S. Patent No. 9,255,143 patent as being part of the cell culture process…terms are only relevant to the asserted formulation patent, 2 AbbVie cannot categorically exclude non-formulation…G1F*”) related to the subject matter of the ’143 patent. Search term 6 is thus not only focused but it…various oligosaccharide forms at issue in the ’143 patent (not “common” terms sharing these letters). 3 | External link to document |
| 2018-06-07 | 119 | Order - -Memorandum and Order | inventions claimed in any patent-in-suit shall not be so limited.” 2 U.S. Patent No. 9,090,867, titled “Fed-Batch…this nature in patent cases because it directly impacts the issues of prior art and patent validity.” BI… given the number of patents and claims at issue, and the evolution of a “patent thicket” over a lengthy… the conception of the patent. That is sure to be a large percentage of patent cases, regardless of whether… and development underlying AbbVie’s asserted patents. Boehringer’s Motion (BI Mot.) at 1 (Doc. No. | External link to document |
| 2018-10-26 | 245 | respect to U.S. Patent No. 9,090,867 (“the ’867 patent”),“Protein A” with respect to U.S. Patent No. 9,018,361…9,018,361 (“the ’361 patent”) and the ’867 patent, and “stable” with respect to U.S. Patent No. 9,272,041 …9,272,041 (“the ’041 patent”). The construction of the terms or phrases on which the parties agree … 2017 15 May 2019 1:17-cv-01065 830 Patent None District Court, D. Delaware | External link to document | |
| 2019-05-15 | 507 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s), 926,975; 9,018,361; 9,090,867; 9,… 2017 15 May 2019 1:17-cv-01065 830 Patent None District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
